CN1038212A - The preparation method of Aining injection - Google Patents
The preparation method of Aining injection Download PDFInfo
- Publication number
- CN1038212A CN1038212A CN 88103250 CN88103250A CN1038212A CN 1038212 A CN1038212 A CN 1038212A CN 88103250 CN88103250 CN 88103250 CN 88103250 A CN88103250 A CN 88103250A CN 1038212 A CN1038212 A CN 1038212A
- Authority
- CN
- China
- Prior art keywords
- preparation
- extracted
- liquid
- water
- alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002347 injection Methods 0.000 title claims abstract description 13
- 239000007924 injection Substances 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims description 12
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000012535 impurity Substances 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 9
- 230000001093 anti-cancer Effects 0.000 claims abstract description 8
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims abstract 3
- 235000011941 Tilia x europaea Nutrition 0.000 claims abstract 3
- 239000004571 lime Substances 0.000 claims abstract 3
- 239000008267 milk Substances 0.000 claims abstract 3
- 235000013336 milk Nutrition 0.000 claims abstract 3
- 210000004080 milk Anatomy 0.000 claims abstract 3
- 239000003814 drug Substances 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 241000208340 Araliaceae Species 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- 241000202726 Bupleurum Species 0.000 claims description 5
- 241000237502 Ostreidae Species 0.000 claims description 5
- 235000020636 oyster Nutrition 0.000 claims description 5
- 238000005325 percolation Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 244000003416 Asparagus officinalis Species 0.000 claims description 3
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 3
- 241001061264 Astragalus Species 0.000 claims description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 3
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 3
- 241000124079 Mylabris Species 0.000 claims description 3
- 235000006533 astragalus Nutrition 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 229940010454 licorice Drugs 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 210000004233 talus Anatomy 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims 1
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000007598 dipping method Methods 0.000 claims 1
- 238000003809 water extraction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 4
- 239000000920 calcium hydroxide Substances 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241000227129 Aconitum Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 235000014375 Curcuma Nutrition 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- JNVCSEDACVAATK-UHFFFAOYSA-L [Ca+2].[S-]SSS[S-] Chemical compound [Ca+2].[S-]SSS[S-] JNVCSEDACVAATK-UHFFFAOYSA-L 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本发明属于药品的制备方法The invention belongs to the preparation method of medicine
癌症对人类健康危害极大,占总死因的第三位。西药治疗肿瘤除具有一定疗效外,尚有明显的毒付作用,致使治疗终止。而中药治疗肿瘤的特点能明显缓解症状,延长患者生存期,无毒付作用。Cancer is extremely harmful to human health, accounting for the third cause of death. In addition to the certain curative effect of Western medicine in treating tumors, there are also obvious toxic effects, which lead to the termination of treatment. The characteristics of traditional Chinese medicine for treating tumors can obviously relieve symptoms, prolong the survival period of patients, and have no toxic side effects.
本发明的癌宁注射液为中药复方,是常用中药。“全国中草药汇编”和“中药大辞典”均有收载。经发明人多年精选配合研究,改进生产工艺,其产品在临床验证明具有肯定的抗癌效果。Aining injection of the present invention is a traditional Chinese medicine compound, which is a commonly used traditional Chinese medicine. Both "National Compilation of Chinese Herbal Medicine" and "Dictionary of Chinese Medicine" are included. After the inventor selected and cooperated with research for many years, and improved the production process, its product has been proved to have a certain anti-cancer effect in clinical trials.
目前,中草药注射液的制备,常用水醇法、石硫法、蒸镏法…等七种方法(药剂学、南京药学院,1982年267-272页),这些均为通用的常规制备方法,但中草药种类繁多,仅用上述制备方法其不足就在于:At present, the preparation of Chinese herbal medicine injections is commonly used in seven methods such as hydroalcohol method, lime sulfur method, distillation method... But Chinese herbal medicine is of a great variety, only with its deficiency of above-mentioned preparation method just to be:
1.制备方法针对性较局限,不能满足众多的单味药及复方需要。因此1. The preparation method is relatively limited in pertinence and cannot meet the needs of numerous single herbs and compound prescriptions. therefore
2.对其有效成分提取及除去杂质等不够满意。2. Unsatisfied with the extraction of active ingredients and removal of impurities.
本发明的目的在于:The purpose of the present invention is to:
针对癌宁中药复方各药的性质特点,对不同的有效成分采用不同的提取方法及除去杂质的方法。使有效成分含量较高,而除去杂质较彻底。Aiming at the properties and characteristics of each drug in the Aining traditional Chinese medicine compound, different extraction methods and impurity removal methods are used for different active ingredients. Make the content of active ingredients higher, and remove impurities more thoroughly.
发明内容:Invention content:
癌宁注射液为中药复方,其构成百分比(W%)如下:Aining injection is a traditional Chinese medicine compound, and its composition percentage (W%) is as follows:
黄芪 20-30 赤芍 6-10Astragalus 20-30 Radix Paeoniae Rubra 6-10
人参 6-12 天冬 6-10Ginseng 6-12 Asparagus 6-10
别甲 20-30 甘草 3-5Biejia 20-30 Licorice 3-5
牡蛎 30-35 蟾酥 0.03-0.07Oyster 30-35 Toad 0.03-0.07
柴胡 6-10 斑蝥 0.1-0.4Bupleurum 6-10 Mylabris 0.1-0.4
上述中药复方为癌宁注射液的主方,根据中医辨证论治的治则。依患者病情,可在主方基础上进行加减。例如:需清热解毒者,可加连翅、黄连、双花。需软坚者,可加莪术、三梭。需活血化瘀者可加当归、红花、三七。需止疼者可加乌头、元胡。上述复方也可减为柴胡、牡蛎二味中药仍具有较好的抗癌效果。The above-mentioned Chinese medicine compound is the main prescription of Aining Injection, and it is based on the principles of TCM syndrome differentiation and treatment. According to the patient's condition, addition and subtraction can be carried out on the basis of the main prescription. For example: For those who need to clear away heat and detoxify, you can add Lian Chi, Huang Lian, and Shuang Hua. Those who need softness and firmness can add Curcuma and Sansuo. Those who need to promote blood circulation and remove blood stasis can add angelica, safflower, and notoginseng. Those who need pain relief can add aconitum and Yuanhu. The above-mentioned compound prescription can also be reduced to the traditional Chinese medicine of bupleurum bupleuri and oyster, which still has a good anticancer effect.
无论主方还是主方的加减方,均按下述生产工艺进行制备。Regardless of the main square or the addition and subtraction of the main square, it is prepared according to the following production process.
癌宁注射液的制备方法:The preparation method of Aining injection:
提取有效成分可水煎煮或用乙醇提取。The active ingredients can be decocted with water or extracted with ethanol.
水煎煮:分二步进行。Water decoction: in two steps.
第一步:用渗漉法提取人参皂甙。先将人参粉碎、润湿、装入渗筒中,加50-75%乙醇浸泡3-4小时,放漉液至浅黄色为止。漉液加热至无醇,药液备用。Step 1: extract ginsenosides by percolation. First crush the ginseng, moisten it, put it into the infiltration cylinder, add 50-75% ethanol to soak for 3-4 hours, and let the liquid drain until light yellow. The filtrate is heated until alcohol-free, and the liquid medicine is set aside.
第二步:水煎提取有效成分,取全部中药(包括第一步人渗渣)加水略高于药液(5-10倍),煮沸三次,分别为半小时、一小时、二小时,将三次药液过滤。将第一、二步提取的药液合并。然后加饱和石灰乳至PH10-13,再通入二氧化硫或加亚硫酸至PH4-6,过滤除去杂Step 2: Decoct in water to extract active ingredients, take all the traditional Chinese medicine (including the dregs of the first step) and add water slightly higher than the liquid medicine (5-10 times), boil three times, half an hour, one hour, two hours respectively, and put Filter the liquid medicine three times. Combine the medicinal liquid extracted in the first and second steps. Then add saturated milk of lime to PH10-13, then add sulfur dioxide or sulfurous acid to PH4-6, filter to remove impurities
质,将滤液浓缩使生药与液体之比为1∶1-2将此浓缩液再加入饱和石灰乳至PH10-13,然后通入二氧化硫或加亚硫酸至PH4.5-6,将药液分装进行高压蒸汽灭菌,取灭菌药液过滤,加入重蒸馏水稀释生药与药液之比为1∶1-15,分装再高压灭菌即可。Concentrate the filtrate so that the ratio of the crude drug to the liquid is 1:1-2, then add saturated milk of lime to the concentrated solution to pH 10-13, then add sulfur dioxide or sulfurous acid to pH 4.5-6, and divide the medicinal solution Pack it for high-pressure steam sterilization, filter the sterilized liquid, add double distilled water to dilute the ratio of crude drug and liquid to 1:1-15, pack it separately and then sterilize it under high pressure.
本发明的癌宁液制备工艺与现有技术相比其优点在于:1.提取的有效成分含量高。2.除去杂质效果好。3.工艺简单。Compared with the prior art, the Aining liquid preparation process of the present invention has the following advantages: 1. The content of the extracted active ingredients is high. 2. Good effect in removing impurities. 3. The process is simple.
实施例:1Example: 1
黄芪28斤 人参8斤 别甲28斤 牡蛎40斤 柴胡8斤 赤芍8斤 天冬8斤 甘草4斤 蟾酥40g 斑蝥200g。Astragalus 28 catties, Ginseng 8 catties, Biejia 28 catties, Oyster 40 catties, Bupleurum 8 catties, Chishao 8 catties, Asparagus 8 catties, Licorice 4 catties, Toad Su 40g, Mylabris 200g.
取人参粉碎湿润后装入渗漉筒加70%乙醇浸泡约3-4小时收取渗漉液至变为浅黄色为止,回收乙醇液体备用。取上述人参渣及其它全部药品加水浸没过药,煮沸半小时,二煎煮沸一小时,三煎煮沸二小时。将三次药液及人参渗漉液合并过滤,然后加饱和石灰乳至PH10以上,然后通二氧化硫PH5,将药液过滤浓缩生药与液体为1∶2。然后再加饱和石灰乳至PH10以上,通入二氧化硫至PH5。药液分装高压消毒灭菌,取药液过滤加重蒸镏水稀释分装,高压消毒灭菌即可。Ginseng is crushed and wetted, put into the percolation cylinder and soaked in 70% ethanol for about 3-4 hours to collect the percolation liquid until it turns light yellow, and recover the ethanol liquid for later use. Take the above-mentioned ginseng residue and all other medicines, add water to immerse the medicines, boil for half an hour, boil for one hour for the second decoction, and boil for two hours for the third decoction. Combine and filter the three medicinal liquids and ginseng percolation liquid, then add saturated milk of lime to a pH above 10, then pass sulfur dioxide to a pH of 5, and filter the medicinal liquid to concentrate crude drug and liquid at a ratio of 1:2. Then add saturated milk of lime to more than PH10, and pass through sulfur dioxide to PH5. The medicinal liquid is subpackaged for high-pressure sterilization, and the medicinal liquid is filtered and diluted with distilled water for subpackage, and then autoclaved and sterilized.
实施例2:Example 2:
取柴胡10斤 牡蛎100斤 加水浸泡煮沸三次,分别煮沸为半小时、一小时、二小时,将三次药液合并过滤,以下制备工艺同实施例1。Take 10 jin of Bupleurum chinensis and 100 jin of oysters, add water, soak and boil three times, boil for half an hour, one hour, and two hours respectively, combine and filter the three medicinal liquids, and the following preparation process is the same as in Example 1.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 88103250 CN1038212A (en) | 1988-06-03 | 1988-06-03 | The preparation method of Aining injection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 88103250 CN1038212A (en) | 1988-06-03 | 1988-06-03 | The preparation method of Aining injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1038212A true CN1038212A (en) | 1989-12-27 |
Family
ID=4832509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 88103250 Pending CN1038212A (en) | 1988-06-03 | 1988-06-03 | The preparation method of Aining injection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1038212A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1049149C (en) * | 1994-07-28 | 2000-02-09 | 杨思齐 | Liver cancer-curing oral liquid prepared with white ant as main material |
| CN1053108C (en) * | 1994-05-24 | 2000-06-07 | 杜仰恩 | Chinese patent medicine for treating primary liver cancer |
| CN1054286C (en) * | 1993-09-23 | 2000-07-12 | 邓辛贵 | Medicine for relieving inflammation and pain |
| CN1060335C (en) * | 1996-01-25 | 2001-01-10 | 王照友 | Anti-cancer injection and its preparation |
| CN100352451C (en) * | 2004-11-03 | 2007-12-05 | 李志业 | Composition for preventing and treating aftosa |
-
1988
- 1988-06-03 CN CN 88103250 patent/CN1038212A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1054286C (en) * | 1993-09-23 | 2000-07-12 | 邓辛贵 | Medicine for relieving inflammation and pain |
| CN1053108C (en) * | 1994-05-24 | 2000-06-07 | 杜仰恩 | Chinese patent medicine for treating primary liver cancer |
| CN1049149C (en) * | 1994-07-28 | 2000-02-09 | 杨思齐 | Liver cancer-curing oral liquid prepared with white ant as main material |
| CN1060335C (en) * | 1996-01-25 | 2001-01-10 | 王照友 | Anti-cancer injection and its preparation |
| CN100352451C (en) * | 2004-11-03 | 2007-12-05 | 李志业 | Composition for preventing and treating aftosa |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102018810B (en) | Preparation method of compound Houttuynia cordata mixture | |
| CN103932173B (en) | A composition for hangover and liver protection | |
| CN1038212A (en) | The preparation method of Aining injection | |
| CN1251736C (en) | Chinese medicinal infusion for treating shingles, parotitis acute mamitis and its manufacturing method | |
| CN1031318C (en) | Method for preparation of oral liquid of agastachis for restoring health | |
| CN1173726C (en) | Medicine for curing malignant turnor and its preparation method | |
| CN103767023B (en) | A hypoglycemic health drink and preparation method thereof | |
| CN117257883A (en) | Method for preparing Huoxiang Zhengqi oral liquid | |
| CN118020937A (en) | Beverage capable of clearing and nourishing throat and preparation method thereof | |
| CN1233343C (en) | Prescription and preparing process for compound spanishneedles ointment | |
| CN104800344B (en) | Traditional Chinese medicine preparation for treating onychomycosis and preparation method thereof | |
| CN1097623A (en) | Treatment chronic nephritis, uremic Chinese medicine preparation and preparation method thereof | |
| CN114984136A (en) | Chinese patent medicine for treating diabetes and preparation method thereof | |
| CN1059800C (en) | Injection containing ginseng and astragalus root components | |
| CN102038813A (en) | Coconut palm leaf extract and preparation method and use thereof | |
| CN106834032A (en) | The application of gout health care product or medicament is controlled in a kind of alcoholic drink mixed with fruit juice, preparation method and its preparation | |
| CN1170562C (en) | Medicine for treating tinea | |
| CN102406790A (en) | A Chinese medicinal capsule for treating mammary gland hyperplasia, and its preparation method | |
| CN1319562C (en) | Disinfectant bactericidal Chinese medicine preparation and producing process thereof | |
| CN1025109C (en) | Method for preparing bitter and cassia holo-element injection | |
| CN116098961A (en) | Beverage for preventing and conditioning cold and preparation method thereof | |
| CN107308342B (en) | Dendrobium eye drops for treating conjunctivitis and keratitis caused by bacterial infection | |
| CN1238041C (en) | Lifuji oral liquor | |
| CN108143944A (en) | A kind of Chinese medicine composition for treating cold | |
| CN104922623A (en) | Pomegranate bark composition for treating persistent dysentery and hematochezia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |